Neuralstem, Inc. has announced that the first patient has been treated in the Phase I trial testing NSI-566 human neural stem cells in the treatment of chronic spinal cord injury at the UC San Diego School of Medicine.
First patient treated In Neuralstem Phase I spinal cord injury stem cell trial
Skip back to main navigation